Drug Profile
CS 4771
Alternative Names: CS-4771Latest Information Update: 27 May 2014
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company
- Class Antibacterials
- Mechanism of Action Toll-like receptor 4 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Sepsis
Most Recent Events
- 27 May 2014 Discontinued - Phase-I for Sepsis in Japan (IV)
- 21 May 2010 Phase-I clinical trials in Sepsis in Japan (IV)